KIT p.Ala829Pro
c.2485G>C · rs1057519713 · VCV375933
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9965 | likely pathogenic ✓ concordant with ClinVar · top 8% in KIT |
|---|---|---|
| REVEL | 0.787 | moderately pathogenic-leaning |
| SaProt | LLR -12.35 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.6, phastCons 1 |
| Regional constraint | o/e 0.46 | unconstrained · MANE · 4,810 bp · p 2.2e-10 · regional, not allelic |
| Overall | ||
| CADD | 34.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Cancer therapy — CIViC
| Disease | Therapies | Level | Significance |
|---|---|---|---|
| Gastrointestinal Stromal Tumor | Ponatinib | D | Sensitivity/Response |
| Gastrointestinal Stromal Tumor | Ponatinib | D | Resistance |
| Gastrointestinal Stromal Tumor | Sunitinib,Imatinib | D | Resistance |
Variant & gene context
- Gene
- KIT
- Protein
- p.Ala829Pro
- Coding
- c.2485G>C
- MANE Select
- NM_000222
- dbSNP
- rs1057519713
- Type
- single nucleotide variant
- Location
- chr4:54736498 (GRCh38)
- Gene constraint
- LOEUF 0.24 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 78.52 · 65 PDB
- Residue 829
- the protein kinase domain; a β-strand; a UniProt-annotated variant site (in a germ cell tumor of the testis; somatic mutation)
Disease context
gastrointestinal stromal tumor — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Gastrointestinal stromal tumor (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- KIT p.Ala621Thr Pathogenic/Likely pathogenic ★★ same condition
- KIT p.Asp820Tyr Pathogenic ★★ same condition
- KIT p.Gln190Ter Pathogenic ★★ same condition
- KIT p.Leu576Pro Pathogenic/Likely pathogenic ★★ same condition
- KIT p.Lys642Glu Pathogenic ★★ same condition
- KIT p.Trp557Arg Pathogenic/Likely pathogenic ★★ same condition
- KIT p.Val559Ala Pathogenic/Likely pathogenic ★★ same condition
- KIT c.1232-3T>C Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/kit-p-ala829pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown